Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer

Pemetrexed, a multitargeting antifolate cytotoxic drug, plays a leading role in front-line chemotherapy for patients with advanced non-squamous non-small-cell lung cancer (NSCLC). Following its approval as second-line monotherapy for locally advanced or metastatic non-squamous NSCLC, pemetrexed has...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Kijima, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217518/
https://www.ncbi.nlm.nih.gov/pubmed/28210147
http://dx.doi.org/10.2147/LCTT.S73268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217518/
https://www.ncbi.nlm.nih.gov/pubmed/28210147
http://dx.doi.org/10.2147/LCTT.S73268

Ejemplares similares